JPRN-C000000413已完成3 期
Validation of genetic diagnosis to predict sensitivity in primary systemic chemotherapy with paclitaxel in women with breast cancer - Validation of genetic diagnosis to predict sensitivity in primary systemic chemotherapy with paclitaxel in women with breast cancer (GENESIS-BC-01)
Cancer Institute Hospital, Japanese Foundation for Cancer Research0 个研究点目标入组 109 人开始时间: 2006年5月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 109
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 70years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Non invasive or microinvasive breast cancer. Stage IIIC, IV. Inflammatory breast caner. Male breast cancer. Previously treated with chemotherapy, hormone therapy or radiotherapy. Active double cancer. Serious complication (infection, cardiac disease, pulmonary fibrosis interstitial pneumonitis, bleeding). Hepatitis type B and its carrier. Uncontrolled diabetes. Heavy history of drug allergy. History of allergic reaction to drugs using the vehicle Cremophor. Pregnant, nursing or willing to be pregnant. Inadequate to entry judged by investigators.
研究者
相似试验
已完成
不适用
Primary ventricular fibrillation and sudden death during a first myocardial infarction: Genetic basisMyocardial infarctionISRCTN11980212niversità degli Studi di Pavia4,000
已完成
不适用
Predictive Value of Genetic Analysis for Pathological Complete Response to Preoperative Treatment in HER2-Positive HR-Negative Early Breast CancerHER2-positive HR-negative breast cancerJPRN-UMIN000028065Japan Agency for Medical Research and development200
进行中（未招募）
不适用
Investigation of genetic predictors of the response to SSRI treatment in patients with panic disorderpanic disorderEUCTR2007-002649-19-EETartu University Hospital Psychiatry Clinic500
已完成
不适用
GENetic and clinical Predictors Of treatment response in DepressioDepressionISRCTN31345163Medical Research Council (UK)887
终止
不适用
Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer PatientsCancerNCT02706652National Cancer Institute (NCI)8